Sunbelt Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $211K | Sell |
5,741
-15,575
| -73% | -$738K | 0.01% | 629 |
|
|
2025
Q4 | $1.08M | Buy |
21,316
+323
| +2% | +$16.5K | 0.07% | 225 |
|
|
2025
Q3 | $1.16M | Buy |
20,993
+7,764
| +59% | +$454K | 0.08% | 210 |
|
|
2025
Q2 | $1.14M | Sell |
13,229
-3,387
| -20% | -$230K | 0.1% | 185 |
|
|
2025
Q1 | $1.15M | Buy |
16,616
+3,387
| +26% | +$280K | 0.1% | 172 |
|
|
2024
Q4 | $1.13M | Buy |
13,229
+643
| +5% | +$69.5K | 0.1% | 185 |
|
|
2024
Q3 | $1.5M | Buy |
12,586
+1,834
| +17% | +$245K | 0.15% | 143 |
|
|
2024
Q2 | $1.53M | Buy |
10,752
+138
| +1% | +$18.3K | 0.16% | 128 |
|
|
2024
Q1 | $1.36M | Sell |
10,614
-1,813
| -15% | -$216K | 0.15% | 138 |
|
|
2023
Q4 | $1.29M | Sell |
12,427
-152
| -1% | -$15K | 0.16% | 143 |
|
|
2023
Q3 | $1.14M | Buy |
12,579
+239
| +2% | +$21.1K | 0.16% | 147 |
|
|
2023
Q2 | $998K | Buy |
12,340
+500
| +4% | +$40.8K | 0.14% | 157 |
|
|
2023
Q1 | $936K | Sell |
11,840
-3,284
| -22% | -$233K | 0.15% | 151 |
|
|
2022
Q4 | $1.02M | Sell |
15,124
-198
| -1% | -$11.6K | 0.2% | 132 |
|
|
2022
Q3 | $763K | Buy |
15,322
+870
| +6% | +$46.6K | 0.16% | 161 |
|
|
2022
Q2 | $805K | Sell |
14,452
-5,612
| -28% | -$311K | 0.17% | 149 |
|
|
2022
Q1 | $1.13M | Sell |
20,064
-702
| -3% | -$36K | 0.21% | 125 |
|
|
2021
Q4 | $1.05M | Sell |
20,766
-566
| -3% | -$30.7K | 0.17% | 141 |
|
|
2021
Q3 | $946K | Hold |
21,332
| – | – | 0.17% | 143 |
|
|
2021
Q2 | $946K | Buy |
21,332
+26
| +0.1% | +$1.01K | 0.17% | 143 |
|
|
2021
Q1 | $718K | Sell |
21,306
-1,820
| -8% | -$64.8K | 0.14% | 182 |
|
|
2020
Q4 | $808K | Sell |
23,126
-814
| -3% | -$28.1K | 0.17% | 149 |
|
|
2020
Q3 | $831K | Sell |
23,940
-1,002
| -4% | -$33.4K | 0.23% | 112 |
|
|
2020
Q2 | $817K | Sell |
24,942
-131,498
| -84% | -$4.2M | 0.28% | 99 |
|
|
2020
Q1 | $4.66M | Buy |
156,440
+116,488
| +292% | +$3.47M | 0.2% | 63 |
|
|
2019
Q4 | $955K | Buy |
39,952
+6,820
| +21% | +$189K | 0.1% | 205 |
|
|
2019
Q3 | $856K | Buy |
33,132
+7,214
| +28% | +$182K | 0.1% | 205 |
|
|
2019
Q2 | $661K | Buy |
25,918
+476
| +2% | +$11.8K | 0.29% | 103 |
|
|
2019
Q1 | $665K | Buy |
25,442
+1,458
| +6% | +$35.8K | 0.33% | 86 |
|
|
2018
Q4 | $552K | Buy |
23,984
+1,930
| +9% | +$42.9K | 0.32% | 87 |
|
|
2018
Q3 | $520K | Buy |
22,054
+28
| +0.1% | +$683 | 0.28% | 101 |
|
|
2018
Q2 | $508K | Buy |
22,026
+4,648
| +27% | +$110K | 0.3% | 93 |
|
|
2018
Q1 | $428K | Sell |
17,378
-13,692
| -44% | -$359K | 0.39% | 83 |
|
|
2017
Q4 | $834K | Sell |
31,070
-42
| -0.1% | -$1.07K | 0.81% | 26 |
|
|
2017
Q3 | $749K | Sell |
31,112
-946
| -3% | -$21.4K | 0.79% | 31 |
|
|
2017
Q2 | $687K | Sell |
32,058
-232
| -0.7% | -$4.68K | 1.29% | 19 |
|
|
2017
Q1 | $553K | Buy |
32,290
+9,504
| +42% | +$165K | 0.83% | 27 |
|
|
2016
Q4 | $409K | Sell |
22,786
-11,448
| -33% | -$208K | 0.62% | 38 |
|
|
2016
Q3 | $712K | Buy |
34,234
+22,464
| +191% | +$557K | 0.86% | 23 |
|
|
2016
Q2 | $316K | Buy |
+11,770
| New | +$323K | 0.41% | 57 |
|
Other funds holding NVO
DAM
F
Sunbelt Securities's NVO Position: Q1 2026 in Review
Sunbelt Securities reduced its Novo Nordisk (NVO) stake by 73% in Q1 2026, selling an estimated $738K and leaving 5,741 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #629.
Sunbelt Securities first reported a position in NVO in Q2 2016 and has held it in 40 quarters since. The position peaked at $4.66M in Q1 2020. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Sunbelt Securities held 5,741 shares of Novo Nordisk worth $211K as of Q1 2026.
- Sunbelt Securities sold 15,575 Novo Nordisk shares in Q1 2026, an estimated $738K.
- Novo Nordisk made up 0.01% of Sunbelt Securities's portfolio in Q1 2026, its #629 holding.
- Sunbelt Securities first reported a position in Novo Nordisk in Q2 2016 and has held it in 40 quarters since.
- Sunbelt Securities's Novo Nordisk position peaked at $4.66M in Q1 2020.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.